Adrenomedullin in heart failure

Hypertension Research

Volumn 26, Issue SUPPL., 2003, Pages

  Nicholls, M Gary ^a   Charles, Christopher J ^a   Lainchbury, John G ^a   Lewis, Lynley K ^a   Rademaker, Miriam T ^a   Richards, A Mark ^a   Yandle, Timothy G ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Adrenomedullin; Aldosterone; Angiotensin; Endothelin; Heart failure

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; ALDOSTERONE RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN; ENKEPHALINASE INHIBITOR; NATRIURETIC PEPTIDE TYPE C; NEUROHORMONE; NITRIC OXIDE; OMAPATRILAT; PROSTAGLANDIN; RECEPTOR ACTIVITY MODIFYING PROTEIN; RECEPTOR BLOCKING AGENT;

CONCENTRATION (PARAMETERS); DISEASE SEVERITY; DRUG RESPONSE; GENE EXPRESSION; HEART; HEART FAILURE; HEART HEMODYNAMICS; HEART PRELOAD; HEART PROTECTION; HORMONE ACTION; HUMAN; KIDNEY; KIDNEY FUNCTION; NONHUMAN; PLASMA; PROTEIN BLOOD LEVEL; REVIEW; SODIUM EXCRETION; URINARY EXCRETION;

ADRENOMEDULLIN; ANIMALS; CARDIOTONIC AGENTS; HEART FAILURE, CONGESTIVE; HUMANS; PEPTIDES;

EID: 0037301008     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.26.S135     Document Type: Review

References (37)

1. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD: Confirmation of a heart failure epidemic: findings from the Resource Utilization among Congestive Heart Failure (REACH) Study. J Am Coll Cardiol 2002; 39: 60-69.
2. Juenger J, Schelberg D, Kraemer S, et al: Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 2002; 87: 235-241.
3. Malek M: Health economics of heart failure. Heart 1999; 82(Suppl IV): IV11-IV13.
4. Kitamura K, Kangawa K, Kawamoto M, et al: Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553-560.
5. Rademaker MT, Cameron VA, Charles CJ, Lainchbury JG, Nicholls MG, Richards AM: Adrenomedullin and heart failure. Regul Pept 2002 (in press).
6. Jougasaki M, Wei C-M, McKinley LJ, Burnett JC Jr: Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 1995; 92: 286-289.
7. Nishikimi T, Saito Y, Kitamura K, et al: Increased plasma levels of adrenomedullin in patients with heart failure. J Am Coll Cardiol 1995; 26: 1424-1431.
8. Kato J, Kobayashi K, Etoh T, et al: Plasma adrenomedullin concentration in patients with heart failure. J Clin Endocrinol Metab 1996; 81: 180-183.
9. Kobayashi K, Kitamura K, Etoh T, et al: Increased plasma adrenomedullin levels in chronic congestive heart failure. Am Heart J 1996; 131: 994-998.
10. Hirayama N, Kitamura K, Imamura T, et al: Molecular forms of circulating adrenomedullin in patients with congestive heart failure. J Endocrinol 1999; 160: 297-303.
11. Etoh T, Kato J, Takenaga M, et al: Differential hormonal profiles of adrenomedullin and proadrenomedullin N-terminal 20 peptide in patients with heart failure and effect of treatment on their plasma levels. Clin Cardiol 1999; 22: 113-117.
12. Nishikimi T, Shibasaki I, Iida H, et al: Molecular forms of adrenomedullin in pericardial fluid and plasma in patients with ischaemic heart disease. Clin Sci 2002; 102: 669-677.
13. Hamada M, Shigematsu Y, Kawakami H, et al: Increased plasma levels of adrenomedullin in patients with hypertrophic cardiomyopathy: its relation to endothelin-1, natriuretic peptides and noradrenaline. Clin Sci 1997; 94: 21-28.
14. Nishikimi T, Nagata S, Sasaki T, et al: Plasma concentrations of adrenomedullin correlate with the extent of pulmonary hypertension in patients with mitral stenosis. Heart 1997; 78: 390-395.
15. Piquard F, Charloux A, Mettauer B, et al: Exercise-induced increase in circulating adrenomedullin is related to mean blood pressure in heart transplant recipients. J Clin Endocrinol Metab 2000; 85: 2828-2831.
16. Richards AM, Nicholls MG, Yandle TG, et al: Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998; 97: 1921-1929.
17. Richards AM, Doughty R, Nicholls MG, et al: Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 2001; 37: 1781-1787.
18. Pousset F, Masson F, Chavirovskaia O, et al: Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure. Eur Heart J 2000; 21: 1009-1014.
19. Cataliotti A, Boerrigter G, Chen HH, et al: Differential actions of vasopeptidase inhibition versus angiotensin-converting enzyme inhibition on diuretic therapy in experimental congestive heart failure. Circulation 2002; 105: 639-644.
20. McClean DR, Ikram H, Mehta S, et al: Vasopeptidase inhibition with omapatrilat in chronic heart failure: acute and long-term hemodynamic and neurohumoral effects. J Am Coll Cardiol 2002; 39: 2034-2041.
21. Romppanen H, Marttila M, Magga J, et al: Adrenomedullin gene expression in the rat heart is stimulated by acute pressure overload: blunted effect in experimental hypertension. Endocrinology 1997; 138: 2636-2639.
22. Nagaya N, Nishikimi T, Yoshihara F, Horio T, Morimoto A, Kangawa K: Cardiac adrenomedullin gene expression and peptide accumulation after acute myocardial infarction in rats. Am J Physiol 2000; 278: R1019-R1026.
23. Øie E, Vinge LE, Yndestad A, Sandberg C, Grøgaard HK, Attramadal H: Induction of a myocardial adrenomedullin signaling system during ischemic heart failure in rats. Circulation 2000; 101: 415-422.
24. Totsune K, Takahashi K, Mackenzie HS, et al: Increased gene expression of adrenomedullin and adrenomedullin-receptor complexes, receptor-activity modifying protein (RAMP) 2 and calcitonin-receptor-like receptor (CRLR) in the hearts of rats with congestive heart failure. Clin Sci 2000; 99: 541-546.
25. Cueille C, Pidoux E, de Vernejoul M-C, Ventura-Clapier R, Garel J-M: Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure. Biochem Biophys Res Commun 2002; 294: 340-346.
26. Willenbrock R, Langenickel T, Knecht M, et al: Regulation of cardiac adrenomedullin-mRNA in different stages of experimental heart failure. Life Sci 1999; 65: 2241-2249.
27. Yoshihara F, Nishikimi T, Okano I, et al: Alterations of intrarenal adrenomedullin and its receptor system in heart failure rats. Hypertension 2001; 37: 216-222.
28. Jougasaki M, Stevens TL, Borgeson DD, Luchner A, Redfield MM, Burnett JC Jr: Adrenomedullin in experimental congestive heart failure: cardiorenal activation. Am J Physiol 1997; 273: R1392-R1399.
29. Jougasaki M, Grantham JA, Redfield MM, Burnett JC Jr: Regulation of cardiac adrenomedullin in heart failure. Peptides 2001; 22: 1841-1850.
30. Hillier C, Petrie MC, Love MP, Johnston F, MacLean MR, McMurray JJV: Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failure. Clin Sci 2001; 101: 45-51.
31. Tsuruda T, Kato J, Kitamura K, et al: An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth. Cardiovasc Res 1999; 43: 958-967.
32. Rademaker MT, Charles CJ, Lewis LK, et al: Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation 1997; 96: 1983-1990.
33. Rademaker MT, Charles CJ, Cooper GJS, et al: Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure. Hypertension 2002; 39: 93-98.
34. Jougasaki M, Heublein DM, Sandberg SM, Burnett JC Jr: Attenuated natriuretic response to adrenomedullin in experimental heart failure. J Card Fail 2001; 7: 75-83.
35. Lainchbury JG, Nicholls MG, Espiner EA, Yandle TG, Lewis LK, Richards AM: Bioactivity and interactions of adrenomedullin and brain natriuretic peptide in patients with heart failure. Hypertension 1999; 34: 70-75.
36. Nagaya N, Satoh T, Nishikimi T, et al: Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation 2000; 101: 498-503.
37. Oya H, Nagaya N, Furuichi S, et al: Comparison of intravenous adrenomedullin with atrial natriuretic peptide in patients with congestive heart failure. Am J Cardiol 2000; 86: 94-98.